Skip to content
GLP-1 Scorecard
Menu
Graded #279

VitaFusions IV

VitaFusions IV (vitafusionsiv.com) offers semaglutide and medical weight loss services in Dallas, TX.

Visit VitaFusions IVWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$149/mo (all doses, plus a separate fee, compounded)
Tirzepatide
$189/mo (all doses, compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Weigh VitaFusions IV against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. Because VitaFusions IV dispenses compounded medication, it’s worth understanding whether compounded semaglutide is legit and safe.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value58/100
Dose & formulation72/100
Clinical oversight74/100
Labs & monitoring53/100
Fulfillment62/100
Contract terms37/100

Strengths

  • Semaglutide confirmed from page metadata
  • Published flat package pricing: semaglutide from $149, tirzepatide $189 for a 7-week supply, no insurance/memberships/contracts

Where it loses points

  • Advertised prices are 7-week package prices, not monthly; homepage banner ('$199 for 7 weeks') conflicts with the program page ('Starting $149')

Bottom line — Grade C

Best for: Shoppers who want pending verification.

Ranked #279 of 499 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Closest on the board

The boards grading nearest VitaFusions IV — the realistic shortlist.

The 20 boards nearest this one

View full scorecard rankings →

Pricing/verification reflect VitaFusions IV's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on VitaFusions IV's site. Not medical advice; see our disclosure.

← Back to the scorecard